Human life expectancy could start creeping up toward the triple digits, according to two leading scientists at the edge of the medical revolution.
Genomics pioneer Craig Venter
In 2000, researchers finished the first draft of the human genome. Although the decreasing cost of the technology has far outpaced Moore’s Law since then, we have yet to fully leverage all that new information, to make it really useful.
Scientists used social-network analysis to find the origins of an outbreak of tuberculosis (top).
It was the baby’s case that first caught people’s attention: an infant in a medium-sized community in British Columbia that was diagnosed with tuberculosis in July 2006. When public health workers took a deeper look at the community’s medical records, they found a number of additional cases suggestive of an outbreak. By December 2008, 41 cases had been identified, bumping up the region’s annual incidence rate by a factor of 10.
Stephen Quake brought the holy grail of personalised medicine a step closer after having all his DNA screened for diseases and susceptibility to treatments.
A scientist has brought the holy grail of personalized medicine a step closer after having all his DNA screened for diseases and susceptibility to treatments. Professor Stephen Quake, at Stanford University, spent $50,000 having his genetic make up mapped and then analysed for different diseases and sensitivity to medication.
Once impenetrable, the individual genetic code is becoming an open book thanks to kits that scan for genes linked to scores of traits and diseases, from bladder cancer and baldness to male infertility and memory loss.